A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC

Clinical trial NCT07141563 · COMPLETED

Trial details

NCT number: NCT07141563
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2025-05-26
Primary completion: 2025-11-18
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.